Chengdu Pioneer released its 2026 semi-annual report on August 26. Both operating income and net profit hit record highs for the same period in history. During the reporting period, the company achieved operating income of 346 million yuan, an increase of 52.41% year on year; realized net profit of 806.753 million yuan, an increase of 61.21% year on year. During the reporting period, with the development of the global innovative pharmaceutical industry, demand for diverse novel molecules from global partners increased, which strongly drove the growth of the company's business in various sectors.

Chengdu Pioneer released its 2026 semi-annual report on August 26. Both operating income and net profit hit record highs for the same period in history. During the reporting period, the company achieved operating income of 346 million yuan, an increase of 52.41% year on year; realized net profit of 806.753 million yuan, an increase of 61.21% year on year. During the reporting period, with the development of the global innovative pharmaceutical industry, demand for diverse novel molecules from global partners increased, which strongly drove the growth of the company's business in various sectors.